CD40ligand‐expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo†Maria A. González-Carmona, Volker Schmitz, Tilman Sauerbruch et al.|Hepatology|2008Cited by 67
Patient‐derived dendritic cells transduced with an a‐fetoprotein‐encoding adenovirus and co‐cultured with autologous cytokine‐induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cellsMaria A. González‐Carmona, Wolfgang H. Caselmann, Angela Märten et al.|Liver International|2006Cited by 46
309 CYTOTOXIC ACTIVITY OF IMMUNOLOGIC EFFECTOR CELLS INDUCED AGAINST HCC BY AFP- OR TUMOR LYSATE-PULSED DENDRITIC CELLS CAN BE SIGNIFICANTLY ENHANCED BY ADENOVIRAL TRANSDUCTION WITH IL-12Maria A. González-Carmona, Wolfgang H. Caselmann, Anne B. Vogt et al.|Journal of Hepatology|2009Cited by 0
375 Dendritic cells co-transduced with an interleukin (IL)-12- or CD40L-expressing adenovirus and an AFP-encoding adenovirus enhance the cytotoxic activity of immunologic effector cells against AFP-expressing HCC cellsMaria A. González-Carmona, Wolfgang H. Caselmann, Cindy Schneider et al.|Journal of Hepatology|2006Cited by 0
539 DENDRITIC CELLS ENGINEERED TO EXPRESS CD40L AND AFP INDUCE TUMOR REGRESSION OF SUBCUTANEOUS HEPATOCELLULAR TUMORS BY ACTIVATING INNATE AND ADAPTIVE IMMUNITY AND BY INDUCING APOPTOSISMaria A. González-Carmona, Wolfgang H. Caselmann, Cindy Schneider et al.|Journal of Hepatology|2008Cited by 0